Tom3 schreef op 25 maart 2021 17:20:
Waarom is Fate vandaag 7% lager?? Is nog steeds $7,1 miljard waard, maar toch. Werpt AFMD zijn schaduw vooruit? Ik verwacht eigenlijk ook CAR achtige resultaten:
In addition, early data from a Phase 1 study evaluating AFM13 preloaded CAR-like cord blood-derived NK cells followed by weekly AFM13 monotherapy in patients with recurrent or refractory CD30-expressing lymphomas at The University of Texas MD Anderson Cancer Center will be presented by Katy Rezvani during a Major Symposium on April 13th.